| Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS |
|
Bone Marrow Transplantation |
Myelodysplastic Syndromes (MDS) |
| In Search for a Haemoglobin Threshold in Myelodysplastic Syndromes |
|
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
| Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease |
|
British Journal of Haematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| The evolving role of next generation sequencing in myelodysplastic syndromes |
|
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
| PNH Phenotypes and Their Genesis |
|
British Journal of Haematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Therapy-related myelodysplastic syndromes in the genomics era |
|
Bulletin du Cancer |
Myelodysplastic Syndromes (MDS) |
| Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes |
|
Cancer |
Myelodysplastic Syndromes (MDS) |
| Good but not good enough: Clinical trial participation of patients with myelodysplastic syndromes |
|
Cancer |
Myelodysplastic Syndromes (MDS) |
| Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS) |
|
Cancer Causes & Control : CCC |
Myelodysplastic Syndromes (MDS) |
| Alcohol use is not a significant contributor to myelodysplastic syndromes |
|
Cancer Causes & Control : CCC |
Myelodysplastic Syndromes (MDS) |
